These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 24397753)
21. Parenteral nutrition product shortages: the A.S.P.E.N. strategy. Mirtallo JM; Holcombe B; Kochevar M; Guenter P Nutr Clin Pract; 2012 Jun; 27(3):385-91. PubMed ID: 22513703 [TBL] [Abstract][Full Text] [Related]
22. Hydroxocobalamin: improved public health readiness for cyanide disasters. Sauer SW; Keim ME Ann Emerg Med; 2001 Jun; 37(6):635-41. PubMed ID: 11385334 [TBL] [Abstract][Full Text] [Related]
23. The Nebraska Veterinary Medical Association antidote depot. Schneider NR J Am Vet Med Assoc; 1987 Mar; 190(6):797-9. PubMed ID: 3570935 [TBL] [Abstract][Full Text] [Related]
24. Treatment of animal toxicoses: a regulatory perspective. Bright SJ; Murphy MJ; Steinschneider JC; Lovell RA; Post LO Vet Clin North Am Food Anim Pract; 2011 Jul; 27(2):481-512, x. PubMed ID: 21575782 [TBL] [Abstract][Full Text] [Related]
25. The impact of anti-infective drug shortages on hospitals in the United States: trends and causes. Griffith MM; Gross AE; Sutton SH; Bolon MK; Esterly JS; Patel JA; Postelnick MJ; Zembower TR; Scheetz MH Clin Infect Dis; 2012 Mar; 54(5):684-91. PubMed ID: 22267747 [TBL] [Abstract][Full Text] [Related]
26. US drug shortages are set to reach record high in 2011, report says. Tanne JH BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406 [No Abstract] [Full Text] [Related]
27. Target: drug shortages: user-fee bill addresses prescription disruptions. Daly R Mod Healthc; 2012 May; 42(22):8-9. PubMed ID: 22745971 [No Abstract] [Full Text] [Related]
28. Efforts underway to curb drug shortages. Jenks S J Natl Cancer Inst; 2011 Jun; 103(12):914-5. PubMed ID: 21693752 [No Abstract] [Full Text] [Related]
29. Antidotes and their availability in South Africa. Wium CA; Hoffman BA Clin Toxicol (Phila); 2009 Jan; 47(1):77-80. PubMed ID: 18608270 [TBL] [Abstract][Full Text] [Related]
30. Prescreening closure formulations for specific applications. Hopkins GH Bull Parenter Drug Assoc; 1975; 29(6):278-85. PubMed ID: 1203606 [No Abstract] [Full Text] [Related]
31. Problems in the supply of antidotes--a view from the pharmaceutical industry. Ruprecht J Toxicology; 2007 Apr; 233(1-3):20-2. PubMed ID: 17110012 [TBL] [Abstract][Full Text] [Related]
32. Access in New Zealand to antidotes for accidental and intentional drug poisonings. Abbott V; Creighton M; Hannam J; Vincent T; Coulter C J Prim Health Care; 2012 Jun; 4(2):100-5. PubMed ID: 22675693 [TBL] [Abstract][Full Text] [Related]
34. Organophosphate antidote auto-injectors vs. traditional administration: a time motion study. Rebmann T; Clements BW; Bailey JA; Evans RG J Emerg Med; 2009 Aug; 37(2):139-43. PubMed ID: 18514464 [TBL] [Abstract][Full Text] [Related]
35. Which cyanide antidote? Hall AH; Saiers J; Baud F Crit Rev Toxicol; 2009; 39(7):541-52. PubMed ID: 19650716 [TBL] [Abstract][Full Text] [Related]
36. [Antidotes--often expensive and not always available]. Hoppu K; Pajarre-Sorsa S Duodecim; 2012; 128(20):2166-75. PubMed ID: 23167174 [TBL] [Abstract][Full Text] [Related]
37. Medication shortages threaten cancer care: the oncology community and the FDA tackle ongoing drug shortage problem. Printz C Cancer; 2012 Jan; 118(2):289-91. PubMed ID: 22222939 [No Abstract] [Full Text] [Related]
38. Can emergency departments not afford to carry essential antidotes? Sivilotti ML; Eisen JS; Lee JS; Peterson RG CJEM; 2002 Jan; 4(1):23-33. PubMed ID: 17637145 [TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacology considerations regarding compounding. Powers TE J Am Vet Med Assoc; 1994 Jul; 205(2):221-3. PubMed ID: 7928581 [No Abstract] [Full Text] [Related]
40. Beware the son of SAMe. Czap A Altern Med Rev; 1999 Apr; 4(2):73. PubMed ID: 10231606 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]